Group Leader
Prof. Fuad Fares
- B.Sc. Biology, Hebrew University, Jerusalem, Israel
- M.Sc. Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
- D.Sc, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
- Post-Doctorate, Department of Molecular Biology & Pharmacology, Washington University, Saint-Louis, MO, USA
- Head of the Molecular Genetic Laboratory, at Carmel Medical Center, Haifa, Israel, for 23 years (1992-2015)
- Faculty member at the Faculty of Medicine, Technion-Israel Institute of Technology (2000-2004)
- Faculty member at Department of Human Biology University of Haifa, Israel (2004-present)
- Member of the Israel Council for Higher Education, for 15 years (2002-2017)
- Developer of ELONVA, [FSH long acting], acquired by Merck & Co. (NYSE: MRK),
- Founder of the technology behind PROLOR Biotech (A Start Up Company) for “Designing long acting recombinant proteins”
- Founder of CanCurX, for “development of new strategies for treatment of cancer” at University of Haifa
Group Members
Lab Manager
Dr. Rinat Bar-Shalom
E-mail: rbar-shal@staff.haifa.ac.il
Tel: 972 4 8288782
Research Associate
Dr. Naiel Azzam
E-mail: nazzam3@univ.haifa.ac.il
Tel: 972 4 8288782
P.h.D Students
- Avishag Zamberg
- Nasreen Nakd
M.Sc. Students
- Hala Gadban
- Lana Abed-Alhak